SAXENA PARAG 13D/13G Filings for Reviva Pharmaceuticals Holdings, Inc. (RVPH)

SAXENA PARAG 13D and 13G filings for Reviva Pharmaceuticals Holdings, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-08-23
4:07 pm
Purchase
2024-08-2213DReviva Pharmaceuticals Holdings, Inc.
RVPH
SAXENA PARAG6,251,606
16.900%
6,251,606increase
(New Position)
Filing